癌症患者畅or不畅？一文讲清便便那些事

1.1 便秘的原因 

1.2 腹泻的原因 

2.1 肿瘤患者便秘分级可采用NCI发布的CTCAE5.0³，即：

2.2 肿瘤患者腹泻的评级通常采用CTCAE标准³，即：

3.1 便秘的应对策略 

3.2 腹泻的应对策略

[1]Dai Q, Yan H, Wu X, Liu Y, Huang F, Dong X. Effectiveness and safety of adjunctive traditional Chinese medicine therapy for constipation after cancer chemotherapy: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020 Aug 21;99(34):e21770.

[2]Moschen AR, Sammy Y, Marjenberg Z, Heptinstall AB, Pooley N, Marczewska AM. The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients. Curr Oncol Rep. 2022 Jul;24(7):861-874.

[3]中华医学会消化病学分会胃肠动力组.中国慢性便秘专家共识意见（2019，广州）[J].中华消化杂志,2019,39(9):577-598.

[4]Common Terminology Criteria for Adverse Events (CTCAE), v5.0. National Institutes and health, National cancer Institute 2017, 2017. National Institutes and Health.(Available:https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_50)

[5]姚小云,陈红宇,胡君娥等.癌症患者化疗相关性便秘评估与管理最佳证据总结[J].护理学报,2020,27(02):48-52.DOI:10.16460/j.issn1008-9969.2020.02.048.

[6]饶堃,彭刚艺.北美国际护理诊断定义与分类（2018—2020）修订解读[J].中华护理教育,2020,17(03):285-288.